Your browser doesn't support javascript.
loading
Letter re: Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients.
Ding, Qian; Guan, Ming-Cheng; Zhu, Hong.
Afiliação
  • Ding Q; Department of Medical Oncology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
  • Guan MC; Department of Medical Oncology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
  • Zhu H; Department of Medical Oncology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China. Electronic address: zhuhong_jasmine@suda.edu.cn.
Eur J Cancer ; 192: 113263, 2023 10.
Article em En | MEDLINE | ID: mdl-37648571
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article